POSTER SESSION VI Wednesday, February 15, 2006   —  1:00 - 4:00 PM Exhibit Level HEMATOPATHOLOGY 130 An Immunohistochemical Evaluation Of MUM1-Positive Follicular Lymphoma:Correlation With CD10, BCL6 And Marginal Zone Differentiation. (1081) TW Kelley, RC Beck, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH 131 Comparison of FISH and PCR for Detection of t(14;18) in Follicular Lymphomas (1061) K Gu, R Hawley, M Cankovic, L Whiteley, J Sanchez, A Adeyinka - Henry Ford Hospital, Detroit, MI 132 The T-Cell Oncoprotein LMO2 Is Expressed in Normal Germinal Center B-Cells and in Germinal Center-Derived B-Cell Lymphoma (1108) Y Natkunam, R Levy, S Zhao, B Taidi, IS Lossos - Stanford University, Stanford, CA; University of Miami, Miami, FL 133 Expression Levels of Active CASPASE 3 Predict Response to Treatment in Diffuse Large B-Cell Lymphomas (1099) M Melachrinou, SF Assimakopoulos, P Matsouka, A Symeonidis, DS Bonikos - Medical School, University of Patras, Patras, Greece 134 Transcription Factor GATA-3 Expression Correlates With Recurrence In Diffuse Large B Cell Lymphoma (1000) AJ Ali, CE Sheehan, T Nazeer, JS Ross, A Hayner-Buchan - Albany Medical College, Albany, NY 135 Protein Profiling of DLBCL Identifies OCT-2, STAT-1 and p53 as Independent Variables for Specific Death (1003) VP Andrade, D Cubero, JHTG Fregnani, FA Soares - Hospital do Cancer, Sao Paulo, Brazil 136 The Alternative NF-kB Pathway is Active in the Majority of Diffuse Large B-cell Lymphomas (1151) B Timar, A Chadburn, DM Knowles, E Cesarman - Weill Medical College of Cornell University, New York, NY 137 Hs.TRAIL/Apo2L Induces Apoptosis In Part Of Chemotherapy Refractory Nodal Diffuse Large B-Cell Lymphomas (1022) SG Cillessen, CJ Meijer, GJ Ossenkoppele, K Castricum, E Hooijberg, JJ Oudejans - VU University Medical Center, Amsterdam, Netherlands 138 FISH Suggests That MIB-1 Labeling Index Is Not A Reliable Distinguisher Of Atypical Burkitt Lymphoma From Diffuse Large B-Cell Lymphoma (1176) X-F Zhao, A Perry, Y Ning, A Hassan, SA Stass, LP Dehner - Washington University School of Medicine, St. Louis, MO; University of Maryland School of Medicine, Baltimore, MD 139 MUM1 And BCL6 But Not HGAL Are Independent Prognostic Indicators Of Outcome In Nodal Diffuse Large B-Cell Lymphoma (1167) NT Wongchaowart, E Segota, B Pohlman, IS Lossos, Y Natkunam, R Levy, T Jin, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH; University of Miami, Miami, FL; Stanford University School of Medicine, Stanford, CA 140 Clinical significance of surface immunoglobulin (sIg) expression in diffuse large B-cell lymphoma (DLBCL). Is IgM expression associated with aggressive disease? (1124) MTS- Rad, DA Stewart, I Auer, J Luider, R Lai, A Mansoor - University of Calgary / Calgary Laboratory Services, Tom Baker Cancer Center, Calgary, AB, Canada; University of Alberta, Edmonton, AB, Canada 141 Immunohistochemical Study of NF-ºB Expression in De Novo Diffuse Large B Cell Lymphoma (1158) C Vejabhuti, SR Sanchez, SL Perkins, CC Chang - Baylor College of Medicine, The Methodist Hospital, Houston, TX; University of Utah, Salt Lake City, UT 142 Primary Diffuse Large B-Cell Testicular Lymphoma Belong To The Non Germinal Center B-Cell-Like Subgroup: Immunohistochemical Study Of 18 Cases (998) MA Al-Abbadi, EM Hattab, MS Tarawneh, SS Amr, T Ulbright, A Orazi - Wayne State Universty, Detroit, MI; Indiana University, Indianapolis, IN; University of Jordan, Amman, Jordan; Dhahran Medical Center, Dhahran, Saudi Arabia 143 Cytogenetic Abnormalities In B-Cell Post-Transplant Lymphoproliferative Disorders: Should Florid Follicular Hyperplasia Be Considered A Precursor? (1153) E Vakiani, C Keller, V Murty, B Alobeid, G Bhagat - Columbia University, New York, NY 144 pSTAT3 Expression in EBV-Positive and EBV-Negative Diffuse Large B Cell Lymphoma and Post-Transplantation Lymphoproliferative Disorders (1028) DR Czuchlewski, GJ Solomon, E Hyjek, A Young, DM Knowles, W Tam, A Chadburn - Weill Medical College of Cornell University, New York, NY 145 Proliferation Of Crippled B-Cell Clones In Post-Transplant Lymphoproliferative Disorders: Rescue By EBV Or Consequence Of Immune Deregulation? (1154) E Vakiani, L Pasqualucci, C Keller, B Alobeid, G Bhagat - Columbia University, New York, NY 146 Role Of CXCL13 In The Pathogenesis Of Bartonella Henselae Monocytoid-B-Cell-Rich, Suppurative Granulomas (1160) W Vermi, F Facchetti, F Gentili, S Sozzani, E Riboldi, R Badolato, M Chilosi, C Doglioni, T Musso - University of Brescia, Brescia, Italy; University of Verona, Verona, Italy; San Raffaele Hospital, Milan, Italy; University of Turin, Turin, Italy 147 HHV8-negative Plasma Cell Variant of Castleman's Disease: An Unusual Plasma Cell Proliferative Disorder Characterized by Monotypic but Polyclonal Plasma Cells (1035) A Dogan, ED Remstein, RF McClure, TC Diss, PJ Kurtin - Mayo Clinic, Rochester, MN; UCL Hospitals, London, United Kingdom 148 The Chemokine CXCL13 (BCA-1) Is Expressed By Follicular Dendritic Cell Sarcoma And Attracts Intratumoral Lymphocytes Expressing CXCR5 (1042) F Facchetti, F Gentili, M Ungari, F Zorzi, S Pileri, M Uguccioni, G Arrigoni, C Doglioni, M Ponzoni - University of Brescia, Poliambulanza, Brescia, Italy; University of Bologna, Bologna, Italy; University of Bern, Bern, Switzerland; San Raffaele Hospital, Milan, Italy 149 Usefulness of Routine Cytogenetic Analysis in Tissues Submitted for "Lymphoma Work-Up" (1036) CH Dunphy, W Tang - UNC, Chapel Hill, NC 150 Large-scale Identification of Proteins Expressed by Follicular Lymphoma-derived Cells in Formalin-fixed Paraffin-embedded Sections (1171) DT Yang, DK Crockett, CP Vaughn, SR Tripp, MS Lim, KSJ Elenitoba-Johnson - University of Utah, ARUP Laboratories, Salt Lake City, UT 151 Utility of Flow Cytometry in Detecting CNS Involvement by Hematopoetic Malignancies (1178) DL Zynger, ND Dimov, D Variakojis, CL Goolsby - Northwestern University, Chicago, IL 152 Technical Validation and Adaptation of the InVivoScribe TCR-gamma and IgH Gene Rearrangement Assays for Detection of Clonal Lymphoid Proliferations (1010) GC Bullock, KA Siegrist, DM Haverstick, MS Mahadevan, LM Silverman, JB Cousar - University of Virginia Health System, Charlottesville, VA 153 Identification Of Genes Involved In Somatic Hypermutation In Small B-Cell Lymphomas (1051) M Garcia-Cosio, L Tracey, M Aggarwal, P Algara, JF Garcia, A Rodriguez, N Martinez, FI Camacho, G Roncador, A Sanchez-Aguilera, E Ruiz-Ballesteros, M Mollejo, JA Garcia-Marco, MA Piris - Hospital Ramon y Cajal, CNIO, Madrid, Spain; Hospital Virgen de la Salud, Toledo, Spain 154 Evaluation Of CD52 Expression In Hematopoietic Neoplasms By Standard Immunohistochemistry: Implications For The Expanded Use Of Alemtuzumab (CAMPATH-1H) In The Treatment Of Hematologic Malignancies. (1132) SJ Rodig, JS Abramson, GS Pinkus, MA Shipp, JL Kutok - Brigham & Women's Hospital, Dana-Farber Cancer Institute, Boston, MA 155 The Accuracy Of Interpretive Criteria For B-Cell Clonality Using PCR With Capillary Gel Electrophoresis For Immunoglobulin Heavy Chain (IgH) Rearrangements (1034) A Djalilvand, CE Hill, KP Mann - Emory University, Atlanta, GA 156 Expression of CD44s And CD44v6 in High And Low Grade Lymphomas (1071) KA Janatpour, J Chen, A Afify - University of California, Davis Medical Center, Sacramento, CA 157 Usefulness Of Core Biopsy In The Diagnosis And Follow Up Of Malignant Lymphomas. A Multidisciplinary Approach In 100 Patients (1089) JI López, JL del Cura, R Zabala, A Fdez-Larrinoa, MV García-Menoyo, E Fuertes, FJ Bilbao - Basurto Hospital, Basque Country Univ (UPV/EHU), Bilbao, Spain 158 Utility of Combined fine-Needle Aspiration / Core Biopsy and Flow Cytometry in Diagnosing and Subclassifying Lymphoma (1093) I Mansoor, B Nelson, C Goolsby - Northwestern Memorial Hospital, Chicago, IL 159 Aberrant Promoter Methylation Of Multiple Genes In Malignant Lymphoma Of B-Cell Type (1020) YD Choi, KH Lee, JH Nam, CSoo Park, C Choi - National Institute of Scientific Investigation, Chang-Sung, Chonnam National University Medical School, Gwang-ju, Republic of Korea